Thromboxane antagonism and cough in chronic bronchitis

Annals of Medicine

Volumn 35, Issue 2, 2003, Pages 135-139

  Ishiura, Yoshihisa ^a,c   Fujimura, Masaki ^b   Yamamori, Chihiro ^b   Nobata, Kouichi ^b   Myou, Shigeharu ^b   Kurashima, Kazuyoshi ^b   Takegoshi, Tadayoshi ^a  

^a Wajima Municipal Hospital   (Japan)

^b KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^c TOYAMA CITY HOSPITAL   (Japan)

Author keywords

Airway cough sensitivity; Chronic bronchitis; Cysteinyl leukotrienes; Thromboxane A2

Indexed keywords

CAPSAICIN; CYSTEINYLLEUKOTRIENE RECEPTOR ANTAGONIST; ICOSANOID; PEPTIDOLEUKOTRIENE; PLACEBO; PRANLUKAST; SERATRODAST; THROMBOXANE RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRONCHUS HYPERREACTIVITY; CHRONIC BRONCHITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CROSSOVER PROCEDURE; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; AGED, 80 AND OVER; BENZOQUINONES; BRONCHITIS; CAPSAICIN; CHROMONES; CHRONIC DISEASE; COUGH; FEMALE; HEPTANOIC ACIDS; HUMANS; LEUKOTRIENE ANTAGONISTS; MALE; MIDDLE AGED; RECEPTORS, THROMBOXANE; RESPIRATORY FUNCTION TESTS;

EID: 0038102548     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.1080/07853890310010032     Document Type: Article

References (26)

1. Kudoh S, Azuma A, Yamamoto M, Izumi T, Ando M. Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am J Respir Crit Care Med 1998; 157: 1829-32.
2. Ishiura Y, Fujimura M, Saito M, Shibata K, Nomura M, Nakatsumi Y, et al. Additive effect of continuous low-dose ofloxacin on erythromycin therapy for sinobronchial syndrome. Respir Med 1995; 89: 677-84.
3. Rich B, Peatfield AC, Williams IP, Richardson PS. Effect of prostaglandin E1, E2, and F2α on mucin secretion from human bronchi in vitro. Thorax 1984; 39: 420-3.
4. Fujimura M, Kamio Y, Kasahara K, Bando T, Hashimoto T, Matsuda T. Prostanoids and cough response to capsaicin in asthma and chronic bronchitis. Eur Respir J 1995; 8: 1499-1505.
5. Rossoni G, Omini C, Vigano T, Mandelli V, Folco GC, Berti F. Bronchoconstriction by histamine and bradykinin in guinea pigs: relationship to thromboxane A2 and the effect of aspirin. Prostaglandins 1980; 20: 547-57.
6. Malini PL, Strocchi E, Zanardi M, Ambrosioni E. Thromboxane antagonism and cough induced by angiotensin-converting-enzyme inhibitor. Lancet 1997; 350: 15-8.
7. Ashida Y, Matsumoto T, Kuriki H, Shiraishi M, Kato K, Terao S. A novel anti-asthmatic quinone derivative, AA-2414 with a potent antagonistic activity against a variety of spasmogenic prostanoids. Prostaglandins 1989; 38: 91-112.
8. Nakagawa N, Obara T, Kobayashi T, Okada Y, Nambu F, Terawaki T, et al. In vivo pharmacologic profile of ONO-1078: a potent, selective and orally effective peptide leuko-triene (LT) antagonist. Jpn J Pharmacol 1992; 60: 217-25.
9. Fujimura M, Abo M, Kamio Y, Myou S, Ishiura Y, Hashimoto T, et al. Effect of leukotriene and thromboxane antagonist on propranolol-induced bronchoconstriction. Am J Respir Crit Care Med 1999; 160: 2100-3.
10. Tamaoki J, Isono K, Nagano Y, Tagaya E, Taira M, Nagai A. Heterogeneity of the roles of leukotriene and thromboxane A2 receptor antagonists in the treatment of moderate to severe asthma. Clin Exp Allergy Reviews 2001; 1: 280-6.
11. Tamaoki J, Kondo M, Sakai N, Nakata J, Takemura H, Nagai A, et al. Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. Am J Respir Crit Care Med 1997; 155: 1235-40.
12. Obase Y, Shimoda T, Matsuo N, Matsuse H, Asai S, Kohno S. Effects of cysteinyl-leukotriene receptor antagonist, thromboxane A2 receptor antagonist, and thromboxane A2 synthetase inhibitor on antigen-induced bronchoconstriction in patients with asthma. Chest 1998; 114: 1028-32.
13. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136: 225-44.
14. Fujimura M, Sakamoto S, Kamio Y, Matsuda T. Effects of methacholine-induced bronchoconstriction and procaterol-induced bronchodilation on cough receptor sensitivity to inhaled capsaicin and tartaric acid. Thorax 1992; 47: 441-5.
15. McEwan JR, Choudry NB, Fuller RW. The effect of sulindac on the abnormal cough reflex associated with dry cough. J Pharmacol Exp Ther 1991; 255: 161-4.
16. Widdicombe JG. Respiratory reflexes from the trachea and bronchi of the cat. J Physiol 1954; 123: 55-70.
17. Aylward M. An assessment of S-carboxymethylcysteine in the treatment of chronic bronchitis. Curr Med Res Opin 1974; 2: 387-94.
18. Higenbottam T. Cough induced by changes of ionic composition of airway surface liquid. Bull Eur Physiopathol Respir 1984; 20: 553-62.
19. Stones R, Barnes PJ, Fuller RW. Contrasting effects of prostaglandins E2 and F2α on sensitivity of the human cough reflex. J Appl Physiol 1992; 73: 649-53.
20. Wasserman MA, Griffin RL, Marsalisi FB. Inhibition of bronchoconstriction by aerosols of prostaglandins E1 and E2. J Pharmacol Exp Ther 1980; 214: 68-73.
21. Kurashima K, Fujimura M, Hoyano Y, Takemura K, Matsuda T. Effect of thromboxane A2 synthetase inhibitor, OKY-046, on sputum in chronic bronchitis and diffuse panbronchiolitis. Eur Respir J 1995; 8: 1705-11.
22. Kadota I, Sakito O, Kohno S, Sawa H, Murae H, Oda H, et al. A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. Am Rev Respir Dis 1993; 147: 153-9.
23. Ogawa H, Fujimura M, Amaike S, Matsumoto Y, Matsuda T. Effect of clarithromycin on cough receptor sensitivity to capsaicin in patients with sinobronchial syndrome. Jpn J Bronchology 1996; 18: 543-7.
24. Hamberg S, Svensson J, Samuelsson B. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci USA 1975; 72: 2994-8.
25. Fujimura M, Sakamoto S, Saito M, Miyake Y, Matsuda T. Effect of a thromboxane A2 receptor antagonist (AA-2414) on bronchial hyperresponsiveness to methacholine in asthmatic subjects. J Allergy Clin Immunol 1991; 87: 23-7.
26. Tamaoki J, Chiyotani A, Kobayashi K, Sakai N, Kanemura T, Takizawa T. Effect of indomethacin on bronchorrhea in patients with chronic bronchitis, diffuse panbronchiolitis, or bronchiectasis. Am Rev Respir Dis 1992; 145: 548-52.